Rapidly detect Clostridium difficile toxin A and B from human fecal samples with a simple, three-step procedure and results in 20 minutes.

in vitro diagnostic test for the direct, qualitative detection of the Clostridium difficile Toxin A gene (tcdA) in unformed stool specimens

For qualitative detection and identification of toxigenic Clostridium difficile bacterial nucleic acids extracted from stool samples

Molecular assay for the detection of C. difficiles in stool

Used for identification of yeast and anaerobic microorganisms primarily Candida albicans and Clostridium difficile.

For good infection control measures

Rapidly detect Clostridium difficile toxin A and B from human fecal samples.

Rapid EIA for the detection of Clostridium difficile toxins A and B in stool samples

Rapid enzyme immunoassay cassette for detecting C. difficile toxins A and B in fecal specimens. Specimens can be run individually or batched.

ELISA for the detection of C. difficile toxins A and B in stool specimens

To be used as full process controls in molecular testing

for the detection of C. difficiles in stool

Rapid ELISA test for qualitative detection of C. difficile antigens

A rapid enzyme immunoassay for the detection of Clostridium difficile common antigen in stool

Rapid enzyme immunoassay for detecting glutamate dehydrogenase (GDH), also known as the C. difficile antigen, in stool specimens. Does not distinguish between toxigenic strains and those that cannot produce toxin.

The Quidel Solana C. difficile Assay is available with Virena, near real-time surveillance information to provide assessment of incidence throughout a health system to monitor C. diff infections.

Uses a tissue culture format to detect the presence of cytotoxic activity (cell rounding) in fecal specimens and confirms the identification of C. difficile toxin by using specific antitoxin.

Molecular assay for the detection of C. difficiles in stool

Enzyme immunoassay for detection of Clostridium difficile common antigen (GDH)